Genertec Universal Medical Group Company Limited (5UM) — Cash Flow-to-Debt Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2023, meaning its operating cash flow of €-1.67 Billion could theoretically repay 0% of its total liabilities (€64.56 Billion) in one year. Check Genertec Universal Medical Group Company investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genertec Universal Medical Group Company Limited Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Genertec Universal Medical Group Company Limited across 10 annual periods. Also explore balance sheet size of Genertec Universal Medical Group Company for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year debt coverage analysis for Genertec Universal Medical Group Company Limited. For market capitalisation and broader financial context, see 5UM market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €5.78 Billion | €59.28 Billion | ▲ +440.7% |
| 2024 | 0.02x | €1.14 Billion | €63.16 Billion | ▼ -78.4% |
| 2023 | 0.08x | €4.99 Billion | €59.98 Billion | ▲ +131.4% |
| 2022 | 0.04x | €2.06 Billion | €57.17 Billion | ▲ +234.3% |
| 2021 | -0.03x | €-1.40 Billion | €52.28 Billion | ▼ -28.3% |
| 2020 | -0.02x | €-971.72 Million | €46.55 Billion | ▲ +49.2% |
| 2019 | -0.04x | €-1.82 Billion | €44.41 Billion | ▲ +73.5% |
| 2018 | -0.15x | €-5.73 Billion | €37.00 Billion | ▲ +7.6% |
| 2017 | -0.17x | €-5.07 Billion | €30.26 Billion | ▼ -57.6% |
| 2016 | -0.11x | €-2.38 Billion | €22.39 Billion | — |